Cytokinetics CYTK Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's change in other assets?
- Cytokinetics (CYTK) reported change in other assets of -$2.06M in Q1 2026.
- How has Cytokinetics's change in other assets changed year-over-year?
- Cytokinetics's change in other assets decreased by 647.1% year-over-year, from $376K to -$2.06M.
- What is the long-term trend for Cytokinetics's change in other assets?
- Over 2 years (2023 to 2025), Cytokinetics's change in other assets has grown at a 35.6% compound annual growth rate (CAGR), from -$1.6M to $2.93M.
- What does change in other assets mean?
- The net change in miscellaneous assets held by the company.
- How do you interpret change in other assets?
- Significant fluctuations may indicate changes in operational scale or timing of prepaid service contracts.
- How does change in other assets compare across companies?
- Standard across all industries; typically represents a small portion of total working capital.